Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

[1]  T. Thom,et al.  Recent status of detection, treatment, and control of hypertension in the community , 2005, Journal of Community Health.

[2]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[3]  D. Lloyd‐Jones,et al.  Treatment and Control of Hypertension in the Community: A Prospective Analysis , 2002, Hypertension.

[4]  K. Flegal,et al.  Prevalence and trends in obesity among US adults, 1999-2000. , 2002, JAMA.

[5]  State-specific trends in self-reported blood pressure screening and high blood pressure--United States, 1991-1999. , 2002, MMWR. Morbidity and mortality weekly report.

[6]  Patricia A. Berglund,et al.  Paper 263-27 Analysis of Complex Sample Survey Data Using the SURVEYMEANS and SURVEYREG Procedures and Macro Coding , 2002 .

[7]  V. Pavlik,et al.  Characteristics of patients with uncontrolled hypertension in the United States. , 2001, The New England journal of medicine.

[8]  S. Oparil,et al.  Effects of ACE Inhibitors, Calcium Antagonists, and Other Blood Pressure lowering Drugs , 2001, Current hypertension reports.

[9]  D. Labarthe,et al.  Birth cohort evidence of population influences on blood pressure in the United States, 1887-1994. , 2001, Annals of epidemiology.

[10]  L. Baines.  Effect of 3 years of antihypertensive therapy on renal structure in type 1 diabetic patients with albuminuria: the European Study for the Prevention of Renal Disease in Type 1 Diabetes (ESPRIT). , 2001, Diabetes.

[11]  C. Schoenborn,et al.  Age adjustment using the 2000 projected U.S. population. , 2001, Healthy People 2010 statistical notes : from the Centers for Disease Control and Prevention/National Center for Health Statistics.

[12]  B Neal,et al.  Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials , 2000, The Lancet.

[13]  J. Manson,et al.  Hypertension and Its Treatment in Postmenopausal Women: Baseline Data from the Women’s Health Initiative , 2000, Hypertension.

[14]  Daniel Levy,et al.  Differential Control of Systolic and Diastolic Blood Pressure: Factors Associated With Lack of Blood Pressure Control in the Community , 2000, Hypertension.

[15]  H. Ward,et al.  Inadequate management of blood pressure in a hypertensive population. , 1999, New England Journal of Medicine.

[16]  Philip D. Harvey,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.

[17]  Joël Ménard,et al.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.

[18]  R. Hoffmann,et al.  Hypertension control and access to medical care in the inner city. , 1998, American journal of public health.

[19]  D. Levy,et al.  Isolated systolic hypertension: an important cardiovascular risk factor. , 1998, Blood pressure.

[20]  K. L. Linton,et al.  Trends in hypertension prevalence, treatment, and control: in a well-defined older population. , 1998, Hypertension.

[21]  R. Gillum,et al.  Validity of self-reported hypertension in the National Health and Nutrition Examination Survey III, 1988-1991. , 1997, Preventive medicine.

[22]  R. Weinshilboum,et al.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. , 1997, Archives of internal medicine.

[23]  W. Kannel,et al.  Framingham study insights into hypertensive risk of cardiovascular disease. , 1995, Hypertension research : official journal of the Japanese Society of Hypertension.

[24]  P Whelton,et al.  Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. , 1995, Hypertension.

[25]  P Whelton,et al.  Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. , 1995, Hypertension.

[26]  Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures. , 1994, Vital and health statistics. Ser. 1, Programs and collection procedures.

[27]  W. Kannel,et al.  Hypertension as a Risk Factor for Cardiac Events—Epidemiologic Results of Long‐Term Studies , 1993, Journal of cardiovascular pharmacology.

[28]  K. Maurer,et al.  Sample design: Third National Health and Nutrition Examination Survey. , 1992, Vital and health statistics. Series 2, Data evaluation and methods research.

[29]  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. , 1991, JAMA.

[30]  ROBERT W. Johnson,et al.  Healthy people. , 1985, Canadian journal of public health = Revue canadienne de sante publique.

[31]  D. Howard.  Esprit , 1978, Telos.

[32]  E H BEALING,et al.  On to the community. , 2018, Nursing times.